Development of a Bioassay System for Human Growth Hormone Determination with Close Correlation to Immunoassay

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of clinical laboratory analysis (Print)

• Publication date

  2012-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcla.21527PMID 23001977PMCID PMC6807445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is BaF3 Bioassay Useful to Identify Patients with Bioinactive Growth Hormone?

  2010cited by this paper
• Laboratory tests and measurements in children born small for gestational age (SGA).

  2006cited by this paper
• Circulating Levels of Insulin-like Growth Factors, their Binding Proteins, and Breast Cancer Risk

  2005influential reference
• Laboratory measurement of growth hormone.

  2004cited by this paper
• Precocious puberty and statural growth.

  2004cited by this paper
• International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001.

  2003cited by this paper
• Serum Levels of Free Insulin-Like Growth Factor (IGF)-I in Normal Children

  2002cited by this paper
• A novel bioassay for human somatogenic activity in serum samples supports the clinical reliability of immunoassays

  2002cited by this paper
• Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males.

  2001cited by this paper
• A novel specific bioassay for serum human growth hormone.

  2000cited by this paper
• Growth hormone in obesity

  1999cited by this paper
• Growth hormone bioactivity and immunoactivity in tall children

  1999cited by this paper
• Growth hormone bioactivity, insulin-like growth factors (IGFs), and IGF binding proteins in obese children.

  1998cited by this paper
• Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency.

  1997cited by this paper
• Biologically inactive growth hormone caused by an amino acid substitution.

  1997cited by this paper
• The full agonistic effect of recombinant 20 kDa human growth hormone (hGH) on CHO cells stably transfected with hGH receptor cDNA.

  1997cited by this paper
• 22-kD growth hormone exclusion assay: a new approach to measurement of non-22-kD growth hormone isoforms in human blood.

  1996cited by this paper
• Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement.

  1996cited by this paper
• The measurement of growth hormone bioactivity in patient serum using an eluted stain assay.

  1995cited by this paper
• The development of an eluted stain bioassay (ESTA) for human growth hormone.

  1995cited by this paper
• Heterogeneity of circulating growth hormone.

  1994cited by this paper
• Assay of Growth Hormone Levels in Human Plasma using Commercial Kits: Analysis of Some Factors Influencing the Results

  1990cited by this paper
• Rabbit liver growth hormone receptor and serum binding protein. Purification, characterization, and sequence.

  1988cited by this paper
• Molecular forms of human growth hormone secreted in vivo: nonspecificity of secretory stimuli.

  1986cited by this paper
• Some properties of the plasma hGH activity in patients with Laron-type dwarfism determined by a radioreceptor assay using human liver tissue.

  1985cited by this paper
• The nature and regulation of the receptors for pituitary growth hormone.

  1985cited by this paper
• A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum.

  1980cited by this paper
• Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH.

  1978cited by this paper
• Binding of 125I-human growth hormone to specific receptors in human cultured lymphocytes. Characterization of the interaction and a sensitive radioreceptor assay.

  1974cited by this paper
• Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization.

  1974cited by this paper
• Differential diagnosis of patients with high twenty-four hour thyroid radioiodine uptakes.

  1966cited by this paper

• Development of lateral flow assay for quantitative analysis of growth hormone.

  2025cites this paper
• Endocrine Diagnostics: Principles and Applications.

  2024cites this paper
• In vivo and in vitro evidence for growth hormone-like bioactivity of Rhizoma Anemarrhenae extract.

  2022cites this paper
• Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy

  2021cites this paper
• The combination of orlistat, lonidamine and 6-diazo-5-oxo-L-norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells.

  2020cites this paper
• Development of reporter gene assays to determine the bioactivity of biopharmaceuticals.

  2019cites this paper
• A Cell-Based Strategy for Bioactivity Determination of Long-Acting Fc-Fusion Recombinant Human Growth Hormone

  2019cites this paper
• Exploiting Nanobodies in the Detection and Quantification of Human Growth Hormone via Phage-Sandwich Enzyme-Linked Immunosorbent Assay

  2017cites this paper
• Generation and characterization of nanobodies against rhGH expressed as sfGFP fusion protein.

  2014cites this paper